Repligen Corporation (RGEN) Stock Overview
Explore Repligen Corporation’s financial performance, market position, analyst ratings, and future outlook.
Repligen Corporation (RGEN)
Key Financials
Key Financials
Market Cap
7.3B
P/E Ratio
143.16
EPS (TTM)
$0.91
ROE
0.02%
RGEN Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Repligen Corporation (RGEN) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 58.45, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $118.54.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 143.16 and a market capitalization of 7.3B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.